US2016256426A1PendingUtilityA1
Composition preventing necrotic enteritis in galloanserans
Est. expiryOct 14, 2033(~7.2 yrs left)· nominal 20-yr term from priority
Inventors:Filip Van ImmerseelRichard SygallKarolien Van DriesscheRichard DucatelleConrad Gerard Schwarzer
A61P 1/04A23K 50/70A61K 31/225A61K 9/0056A23K 50/75A61K 9/167A61K 9/50A23K 20/158A61K 31/22A23V 2002/00
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention refers to the use of a glycerol ester composition of at least one short chain fatty acid for preventing and/or alleviating necrotic enteritis in the gastric tract of galloanserans. The glycerol ester composition comprises at least 75% by weight of glyceryl tributyrate, below 25% by weight of glyceryl dibutyrate and below 8% by weight of glyceryl monobutyrate. The present invention also refers to the use of said composition for modulating the gut flora of galloanserans.
Claims
exact text as granted — not AI-modified1 . A glycerol ester composition comprising at least 75% by weight of glyceryl tributyrate, below 25% by weight of glyceryl dibutyrate and below 8% by weight of glyceryl monobutyrate, for use in prevention and/or alleviation of necrotic enteritis in the gastric tract of galloanserans.
2 . A glycerol ester composition according to claim 1 , wherein said necrotic enteritis is caused by Clostridium perfringens.
3 . A glycerol ester composition according to claim 1 , wherein said galloanserans are galliformes.
4 . A glycerol ester composition according to claim 1 , wherein said galloanserans are anseriforms.
5 . A glycerol ester composition according to claim 1 , wherein said glycerol ester composition comprises at least 80% by weight of glyceryl tributyrate, below 20% by weight of glyceryl dibutyrate and below 5% by weight of glyceryl monobutyrate.
6 . A glycerol ester composition according to claim 1 , wherein said glycerol ester composition comprises at least 85% by weight of glyceryl tributyrate, below 15% by weight of glyceryl dibutyrate and below 4% by weight of glyceryl monobutyrate.
7 . A glycerol ester composition according to claim 1 , wherein said glycerol ester composition comprises at least 90% by weight of glyceryl tributyrate, below 10% by weight of glyceryl dibutyrate and below 2.5% by weight of glyceryl monobutyrate.
8 . A glycerol ester composition according to claim 1 , wherein the amount of free butyric acid in said glycerol ester composition is below 1% by weight.
9 . A glycerol ester composition according to claim 1 , wherein the amount of free butyric acid in said glycerol ester composition is below 0.5% by weight.
10 . A glycerol ester composition according to claim 1 , wherein the amount of free butyric acid in said glycerol ester composition is below 0.2% by weight.
11 . A glycerol ester composition according to claim 1 , wherein said glycerol ester composition is adsorbed on a carrier, such as a silica carrier, thereby allowing said glycerol ester composition to be distributed as a dry product.
12 . A glycerol ester composition according to claim 11 , wherein said carrier comprises porous silica particles with an average particle size of 20-70 μm.
13 . A glycerol ester composition according to claim 11 , wherein said glycerol ester composition is adsorbed on silica particles in a weight ratio of 50-80% glycerol ester and 20-50% silica particles.
14 . A glycerol ester composition according to claim 1 , wherein said glycerol ester composition is fed to said galloanserans in an amount of between 0.05 to 1.5% by weight of the galloanserans' daily feed ration.
15 . A glycerol ester composition according to claim 1 , wherein said glycerol ester composition is fed to said galloanserans in an amount of between 0.1 to 1.0% by weight of the galloanserans' daily feed ration.
16 . A glycerol ester composition according to claim 14 , wherein said amount of said glycerol ester composition is administered over time intervals of 5-10 days and wherein said amount is decreased over a 1-5 week period.
17 . A glycerol ester composition according to claim 16 , wherein the decrease of said amount is 20-50% of the amount given during the previous interval.
18 . A glycerol ester composition according to claim 15 , wherein said amount of said glycerol ester composition is administered over time intervals of 5-10 days and wherein said amount is decreased over a 1-5 week period.
19 . A glycerol ester composition according to claim 3 , wherein said galloanserans are galliformes selected from the group consisting of chicken, turkey, grouse and pheasant.
20 . A glycerol ester composition according to claim 4 , wherein said galloanserans are anseriforms selected from the group consisting of ducks, goose and swan.Join the waitlist — get patent alerts
Track US2016256426A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.